IN-DEPTH: The Hair Loss Drug Leaving Victims With a Debilitating Condition

Patients fear finasteride is sold without clear warnings

Signage is seen at the Merck & Co. headquarters in Kenilworth, N.J., on Nov. 13, 2021. Andrew Kelly/Reuters

Post-finasteride syndrome (PFS) which is brought on by the hair loss product finasteride, is causing some men to have a life-long debilitating illness and suicidal thoughts. With no cure in sight, victims are calling on authorities to take the condition seriously, warn others and regulate its sale at online clinics.

Victims are hoping that an upcoming investigation by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) will shed some light on their condition.